• Frontier Biotech gets $43m from Huaxin Century, others dealstreetasia
    January 16, 2017
    Frontier Biotechnologies Inc.,has raised $43 million (RMB300 million) in a series C funding round led by Chinese RMB fund Huaxin Century Investment Group, as per a China Money Network report.
PharmaSources Customer Service